CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 884546
SAN FRANCISCO, CA
Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,355,910
-$123,452 QoQ
Shares Held
2,514,240
-1.9% QoQ
Ownership
0.801%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. FOLD ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,355,910 | 2,514,240 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,479,362 | 2,561,753 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,686,532 | 2,752,098 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,600,360 | 2,548,056 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,327,212 | 2,491,080 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $24,367,684 | 2,586,803 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $28,486,454 | 2,667,271 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,052,022 | 2,424,599 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $27,411,200 | 2,326,927 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $32,195,492 | 2,268,886 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $26,492,882 | 2,178,691 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $26,451,573 | 2,106,017 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $22,913,692 | 2,066,158 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $25,215,884 | 2,065,183 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,095,742 | 2,020,665 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,352,580 | 1,988,136 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,984,830 | 2,004,734 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $22,610,476 | 1,957,617 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $17,867,410 | 1,870,933 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $20,036,778 | 2,078,504 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,962,806 | 2,020,527 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $43,824,058 | 1,897,967 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $26,734,652 | 1,893,389 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $29,001,358 | 1,923,167 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $16,992,286 | 1,838,992 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||